Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals Inc (ADMS)

Market is closed
News
13G Filing: Point72 Asset Management and Adamas Pharmaceuticals Inc (ADMS)

13G Filing: Point72 Asset Management and Adamas Pharmaceuticals Inc (ADMS)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...

Keep Reading →

October 27th, 2017 - Hedge Funds

13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)

13G Filing: Great Point Partners and Adamas Pharmaceuticals Inc (ADMS)

The Reporting Persons have entered into a Joint Filing Agreement, dated October 10, 2017, a copy of which is filed with this Schedule 13G/A as Exhibit A, pursuant to which the Reporting Persons have agreed...

Keep Reading →

October 11th, 2017 - Hedge Funds

13G Filing: Armistice Capital and Adamas Pharmaceuticals Inc (ADMS)

13G Filing: Armistice Capital and Adamas Pharmaceuticals Inc (ADMS)

*  The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing...

Keep Reading →

June 1st, 2017 - Hedge Funds

Adamas Pharmaceuticals Inc (ADMS) Is Up On PDUFA: What's Next?

Adamas Pharmaceuticals Inc (ADMS) Is Up On PDUFA: What's Next?

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is up close to 15% on its 2017 open, on the back of a couple of positive developments out of its Parkinson’s disease pipeline.

Keep Reading →

January 9th, 2017 - News Stock Analysis

Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?

Is Adamas Pharmaceuticals Inc (ADMS) A Good Stock To Buy?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.

Keep Reading →

December 8th, 2016 - Hedge Funds News

This Biotech Hedge Fund's Stock Picks Killed It in Q3

This Biotech Hedge Fund's Stock Picks Killed It in Q3

Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again.

Keep Reading →

November 2nd, 2016 - Hedge Funds News

5 Healthcare Stocks Near the Top of Cheyne Capital's Portfolio

5 Healthcare Stocks Near the Top of Cheyne Capital's Portfolio

London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC.

Keep Reading →

August 10th, 2016 - Hedge Fund Analysis Hedge Funds News

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (ADMS) And Acorda Therapeutics Inc (ACOR)

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (ADMS) And Acorda Therapeutics Inc (ACOR)

We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the companies in question.

Keep Reading →

August 5th, 2016 - News Stock Analysis

Taking A Look At Adamas Pharmaceuticals Inc (ADMS)’s Upcoming Parkinson’s NDA

Taking A Look At Adamas Pharmaceuticals Inc (ADMS)’s Upcoming Parkinson’s NDA

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) just announced its intention to submit an NDA for its lead Parkinson’s candidate before the year draws to a close.

Keep Reading →

June 23rd, 2016 - News Stock Analysis

Why Are These Four Stocks in The Spotlight Today?

Why Are These Four Stocks in The Spotlight Today?

With all three indexes roughly flat in morning trading as many veteran market participants kick back for the holidays and the rookies try to hold the fort, California Resources Corp (NYSE:CRC), Bill...

Keep Reading →

December 24th, 2015 - Market Movers News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)